Jefferies Downgrades VistaGen Therapeutics (VTGN) to Hold
Get Alerts VTGN Hot Sheet
Price: $5.28 +15.54%
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Jefferies analyst Andrew Tsai downgraded VistaGen Therapeutics (NASDAQ: VTGN) from Buy to Hold with a price target of $0.20 (from $8.00).
For an analyst ratings summary and ratings history on VistaGen Therapeutics click here. For more ratings news on VistaGen Therapeutics click here.
Shares of VistaGen Therapeutics closed at $1.07 yesterday.
You May Also Be Interested In
- Teleperformance (TEP:FP) (TLPFY) PT Lowered to EUR125 at RBC Capital, 'perceived risk profile makes it a no-fly zone for many investors'
- BofA Securities Downgrades Galapagos NV (GLPG) to Underperform
- Sidoti Downgrades Construction Partners Inc (ROAD) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!